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MaOBJECTIVES The goal of this study was to assess the relationship among extracellular volume (ECV), native T1, and
systolic strain in hypertensive patients with left ventricular hypertrophy (HTN LVH), hypertensive patients without LVH
(HTN non-LVH), and normotensive controls.
BACKGROUND Diffuse myocardial ﬁbrosis in HTN LVH patients, as reﬂected by increased ECV and native T1, may be
an underlying mechanism contributing to increased cardiovascular risk compared with HTN non-LVH subjects and con-
trols. Furthermore, increased diffuse ﬁbrosis in HTN LVH subjects may be associated with reduced peak systolic and early
diastolic strain rate compared with the other 2 groups.
METHODS T1 mapping was performed in 20 HTN LVH (mean age, 55  11 years), 23 HTN non-LVH (mean age, 61  12
years), and 22 control subjects (mean age, 54  7 years) on a Siemens 1.5-T Avanto (Siemens Healthcare, Erlangen,
Germany) using a previously validated modiﬁed look-locker inversion-recovery pulse sequence. T1 was measured pre-
contrast and 10, 15, and 20 min after injection of 0.15 mmol/kg gadopentetate dimeglumine, and the mean ECV and
native T1 were determined for each subject. Measurement of circumferential strain parameters were performed using cine
displacement encoding with stimulated echoes.
RESULTS HTN LVH subjects had higher native T1 compared with controls (p < 0.05). HTN LVH subjects had higher ECV
compared with HTN non-LVH subjects and controls (p < 0.05). Peak systolic circumferential strain and early diastolic
strain rates were reduced in HTN LVH subjects compared with HTN non-LVH subjects and controls (p < 0.05). Increased
levels of ECV and native T1 were associated with reduced peak systolic and early diastolic circumferential strain rate
across all subjects.
CONCLUSIONS HTN LVH patients had higher ECV, longer native T1 and associated reduction in peak systolic circum-
ferential strain, and early diastolic strain rate compared with HTN non-LVH and control subjects. Measurement of ECV
and native T1 provide a noninvasive assessment of diffuse ﬁbrosis in hypertensive heart disease. (J Am Coll Cardiol Img
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AB BR E V I A T I O N S
AND ACRONYM S
CMR = cardiac magnetic
resonance
ECV = extracellular volume
EF = ejection fraction
FOV = ﬁeld of view
Hct = hematocrit
HTN = hypertension
LGE = late gadolinium
enhancement
LV = left ventricle
LVH = left ventricular
hypertrophy
LVMI = left ventricular
mass index
MOLLI = modiﬁed look-locker
inversion recovery
TE = echo time
TR = repetition time
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173H ypertension (HTN) is a common cause ofmorbidity and mortality in the UnitedStates affecting 1 in 3 adults (1). Patients
with long-standing or poorly controlled HTN are at
increased risk for developing left ventricular hyper-
trophy (LVH) and diastolic dysfunction (2). LVH is
an independent risk factor for cardiovascular
morbidity and mortality in hypertensive patients
(3,4). Diffuse ﬁbrosis has been detected in subjects
with HTN with LVH in both biopsy (5) and autopsy
studies (6) and has been linked to the development
of LVH and diastolic dysfunction (7). Concentric LVH
portends higher cardiovascular morbidity and mortal-
ity compared with other hypertrophy subtypes (8).
The presence of diffuse ﬁbrosis may confer increased
cardiovascular risk in HTN LVH patients.
Diffuse myocardial ﬁbrosis in hypertensive LVH is
not detected by conventional late gadolinium
enhanced (LGE) cardiac magnetic resonance (CMR).
T1 mapping is a novel CMR approach that is able to
detect diffuse ﬁbrosis in diseases such as aortic ste-
nosis and hypertrophic cardiomyopathy as validated
against myocardial biopsy (9). By measuring the T1
relaxation times of the blood and myocardium both
pre- and post-contrast, one can determine the parti-
tion coefﬁcient (l) of gadolinium and, subsequently,
the extracellular volume (ECV).SEE PAGE 181We hypothesized that HTN LVH patients would
show diffuse myocardial ﬁbrosis as measured by T1
mapping and ECV compared with HTN non-LVH and
normotensive controls. We also postulated that sub-
jects with HTN LVH would have greater ﬁbrosis and
reduced systolic strain, and early diastolic strain rate
compared with the other 2 groups.
METHODS
Twenty subjects with HTN LVH (mean age, 55  11
years), 23 subjects with HTN non-LVH (mean age, 61
 12 years), and 22 normotensive controls (mean age,
54  7 years) were enrolled between November 2010
and October 2013 under an institutional review
board–approved protocol. All subjects signed in-
formed consent. Patients with a history of HTN and
evidence of LVH by any imaging modality were
considered for this study. Patients with any other
causes of LVH, known coronary disease, signiﬁcant
valvular disease, renal impairment with glomerular
ﬁltration rate <45 ml/min/1.73 m2 or reduced sys-
tolic function (ejection fraction [EF] <45%) were ex-
cluded. Subjects with a history of HTN with systolic
blood pressure >140 mm Hg or diastolic bloodpressure >90 mm Hg on at least 2 ofﬁce
readings (10), or taking 1 or more medications
for hypertension, were included. Subjects
were then classiﬁed as having LVH if their left
ventricular mass indexed by body surface
area (LVMI) as measured by cardiac magnetic
resonance imaging was >81 g/m2 for men or
>61 g/m2 in women as deﬁned by Olivotto
et al. (11). Hypertensive subjects not meeting
criteria for LVH as deﬁned in the preceding
text were included in the HTN non-LVH
group. Healthy volunteers who were normo-
tensive and did not have a history of HTN
were enrolled in the control arm.
CMR PROTOCOL. CMR was performed on a
1.5-T magnetic resonance scanner (Siemens
Avanto, Erlangen, Germany).
Cine Imaging. Left ventricular (LV) mass and
function were assessed by steady-state free-
precession cine imaging using the following
sequence parameters: repetition time (TR) 2.7 ms,
echo time (TE) 1.3 ms, ﬂip angle 70, ﬁeld of view
(FOV) 300 to 350 mm, and in-plane resolution 1.8 
1.4 mm, TR 40 to 50 ms, slice thickness 8 mm. Images
were obtained in short-axis and standard long-axis
orientations. Analyses were performed (R.J., S.K.)
using Argus software (Siemens Healthcare, Princeton,
New Jersey) on a Leonardo workstation (Siemens
Healthcare, Erlangen, Germany). End-diastolic and
end-systolic endocardial and epicardial cavity areas
were planimetered for each short-axis slice. The LV
mass, end-diastolic volume, and end-systolic vol-
umes were determined and indexed to body surface
area. LV mass was measured from the end-diastolic
image frames using the validated Q-Mass version 7.5
(Medis Medical Imaging, Leiden, the Netherlands)
program (12). Papillary muscles were included when
measuring LV mass as per recent Society for Cardio-
vascular Magnetic Resonance guidelines (13).
T1 mapping. T1 mapping was performed using a
reduced breath-hold variant of the modiﬁed look-
locker inversion recovery (MOLLI) technique (14),
which was previously validated by our group (15).
This protocol yields 8 T1-weighted source images
over 11 heartbeats. The starting TI (to the ﬁrst image
readout) was chosen to be 100 ms, with an increment
of 80 ms for the subsequent look-locker trains. The
pulse sequence parameters included: TE 1.1 ms, TR
2.5 ms, ﬂip angle 35, FOV 340  260 mm, resolution
1.8  1.8 mm and slice thickness of 8 mm.
T1 maps (Figure 1) were obtained in basal and mid-
ventricular short axis slices pre-contrast and at 10,
15, and 20 min after a bolus intravenous injection of
FIGURE 1 Example T1 Maps
T1 maps pre-contrast (left) and post-contrast (right). T1 maps are generated from
a collection of T1 images obtained at different inversion times during the same phase
of the cardiac cycle.
TABLE 1
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1740.15 mmol/kg gadopentetate dimeglumine (Gd-DTPA)
(Magnevist, Bayer Healthcare, Berlin, Germany).
Hematocrit (Hct) was measured in all subjects.
Late gadolinium enhancement. LGE images were ac-
quired approximately 10 to 15 min after bolus injection
of 0.15 mmol/kg of Gd-DTPA. A phase sensitive inver-
sion recovery sequence was used (TR 7.1ms, TE 3.4ms,
ﬂip angle 25, FOV 300 to 340 mm, resolution 1.8  1.3,
slice thickness 8 mm). LGE images were scored visu-
ally by 2 experienced observers (S.K., M.S.).
Strain imaging. A spiral cine displacement encoding
with stimulated echoes-pulse sequence was used to
quantify circumferential strain and strain rate.
Sequence parameters included: TR 17 ms, TE 1.8 ms,
ﬂip angle 20, FOV 350 mm2, resolution 2.5 mm  2.5
mm, slice thickness 8 mm, number of spiral in-
terleaves 6, temporal resolution 34 ms (16,17). Images
were obtained in basal and mid short-axis locations.Baseline Characteristics of HTN LVH Subjects, HTN Non-LVH
and Controls
Normotensive
Controls
(n ¼ 22)
Hypertensive
Non-LVH
(n ¼ 23)
Hypertensive
LVH
(n ¼ 20)
15 F; 7 M 13 F; 10 M 14 F; 6 M
54 (48–61) 64 (56–71) 55 (44–66)
P (mm Hg) 123  14 135  16* 151  21*†
P (mm Hg) 71  11 77  11 84  16*
(beats/min) 73  12 73  14 71  10
f HTN
nes
0 2.1  1.1* 3.6  1.2*†
g) 92  20 115  31 171  39*†
2) 49  7 55  9 83  14*†
olume ratio 0.71  0.19 0.87  0.21 1.30  0.40*†
, median (interquartile range), or mean  SD. *p < 0.05 vs. controls. †p < 0.05 vs.
oups.
od pressure; F ¼ female; HTN ¼ hypertension; LV ¼ left ventricular; LVH ¼ left
hypertrophy; LVMI ¼ left ventricular mass index; M ¼ male.Data analysis. T1 maps were calculated from the MOLLI
data using a nonlinear least squares ﬁt of the signal
intensity versus TI on a pixel-by-pixel basis, and the
endocardial and epicardial borders of the myocar-
dium were manually segmented using a previously
validated custom MATLAB script (MathWorks, Natick,
Massachusetts) (15). The mean T1 in a region of in-
terest in the ventricular cavity was taken as the blood
T1. The partition coefﬁcient (l) was determined from
the slope of a plot of 1/T1 of the myocardium versus
1/T1 of the blood. Data from both the mid and basal
slices pre-contrast and at time points 10, 15, and 20
min post-contrast were used for the ﬁtting. The ECV
was calculated as: (1  Hct) $ l.
Peak systolic circumferential strain and early dia-
stolic strain rates were computed ofﬂine from cine
displacement encoding with stimulated echo images
with a custom MATLAB script using previously
described methods (18,19).
STATISTICAL ANALYSIS. All continuous variables
are expressed as their mean and standard deviation.
All statistical analysis was performed using SPSS
version 21 (IBM Corporation, Armonk, New York).
Values were compared between groups using 1-way
analysis of variance, the Scheffe method was used
to control for multiple pairwise corrections. Age and
number of blood pressure medications for the 3
groups as shown in Table 1 were reported as median
scores with interquartile ranges. Comparisons be-
tween groups of non-normally distributed variables
were performed using the Kruskal-Wallis test. Corre-
lation analysis used the Pearson correlation coefﬁ-
cient for linear associations, and the Spearman rank
correlation coefﬁcient for monotonic nonlinear asso-
ciations. A p value <0.05 was considered signiﬁcant.
RESULTS
Table 1 shows the baseline characteristics of the 3
groups. The groups had similar values for heart rate,
LVEF, and Hct. The systolic and diastolic blood
pressures were signiﬁcantly higher in the HTN LVH
group than the HTN non-LVH and control subjects.
LV mass was higher in the HTN LVH group by
study design. Two subjects (both in the HTN non-
LVH group) had focal areas of late enhancement:
1 subject had right ventricular insertion site
hyperenhancement, and the other had a focal area of
midwall enhancement in the distal inferior wall,
considered to be nonischemic in origin. These regions
were not included on T1 mapping analysis to mini-
mize potential bias from including regions with
focal ﬁbrosis. Left ventricular mass/volume ratios
for the 3 groups were calculated. Left ventricular
TABLE 2 ECV, Partition Coefﬁcient, and Native T1 Values in HTN LVH
Subjects Versus Non-LVH and Controls
Normotensive
Controls (n ¼ 22)
Hypertensive
Non-LVH (n ¼ 23)
Hypertensive
LVH (n ¼ 20)
Extracellular volume 0.26  0.02 0.27  0.02 0.29  0.03*†
Native T1 (ms) 967.4  35.0 974.0  33.6 996.0  32.5†
Partition coefﬁcient (l) 0.43  0.03 0.45  0.03 0.48  0.04*†
Values are mean  SD. *p < 0.05 vs. non-LVH groups. †p < 0.05 vs. controls.
ECV ¼ extracellular volume; HTN ¼ hypertensive; LVH ¼ left ventricular hypertrophy.
FIGURE 2 ECV of Gadolinium Among the 3 Groups
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Box plot showing the distribution of ECV among the 3 study groups. Boxes represent the
25th to 75th percentiles, and horizontal lines within the boxes represent the median
values. ECV ¼ extracellular volume; HTN ¼ hypertension; LVH ¼ left ventricular hyper-
trophy; LVMI ¼ left ventricular mass index.
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175mass/volume ratios were higher in the HTN LVH
groups compared with the other 2 groups (Table 1)
(Online Appendix).
ECV. ECV was signiﬁcantly higher in HTN LVH sub-
jects versus controls (0.29  0.03 vs. 0.26  0.02,
p < 0.01) and HTN non-LVH subjects (0.29  0.03 vs.
0.27  0.02, p ¼ 0.05) (Table 2, Figure 2). There were
no differences in ECV (p ¼ 0.6) between HTN non-LVH
and control subjects. Similar ﬁndings were seen with
partition coefﬁcient (l) (Table 2) (Online Appendix).
NATIVE T1. The native T1 of the patients with HTN
LVH was longer than that of control subjects (996  32
vs. 967  35, p ¼ 0.007) (Table 2). Although the point
estimate of native T1 in the HTN non-LVH group was
higher than that of controls, this difference was not
statistically signiﬁcant (Table 2). Post-contrast T1
values are provided in the data supplement.
RELATIONSHIP AMONG ECV, NATIVE T1, AND
LVMI. A positive association was noted between
LVMI and ECV (Figure 3A) (Spearman rho ¼ 0.26,
p ¼ 0.03). However, ECV was not linearly related to an
increase in LVMI. HTN non-LVH subjects had similar
LVMI and ECV levels to those of controls. HTN LVH
subjects had higher LVMI levels as expected and had
higher ECV levels. However, subjects with the highest
LVMI did not show a proportional increase in ECV.
Furthermore, certain HTN LVH subjects with rela-
tively lower LVMI had signiﬁcantly higher levels of
ECV (>0.30). Similarly, a positive association was
noted between native T1 levels and LVMI (Figure 3B)
(Spearman rho ¼ 0.36, p ¼ 0.03).
ECV, NATIVE T1, CIRCUMFERENTIAL STRAIN, AND
STRAIN RATE. Figure 4A shows average circumfer-
ential strain-time curves from the 3 groups.
Peak circumferential strain at both base and mid-
ventricular levels was reduced in HTN LVH subjects-
compared with both controls and HTN non-LVH
subjects (Table 3). ECV correlated with peak circum-
ferential strain (R ¼ 0.26, p ¼ 0.05) (Figure 5A).
Figure 4B shows average circumferential strain rate
versus time curves in the 3 groups. The average early
diastolic circumferential strain rate (e0SR) was reduced
in HTN LVH subjects compared with both controls
and HTN non-LVH subjects (0.49  0.26 vs. 0.82 
0.16, p < 0.0001 and 0.49  0.26 vs. 0.71  0.18, p ¼
0.02, respectively) (Table 3). The results were similar
for early diastolic circumferential strain rates at both
the basal and mid-ventricular levels (Table 3). ECV
correlated signiﬁcantly with average early diastolic
circumferential strain rate (R ¼ 0.34, p ¼ 0.01)
(Figure 5B). Radial strain measurements were also
performed and are presented in the data supplement.
Native T1 correlated signiﬁcantly with peak systoliccircumferential strain (R ¼ 0.44, p < 0.0001)
(Figure 6A). Native T1 also correlated signiﬁcantly
with e0SR (R ¼ 0.40, p <0.01) (Figure 6B).
LV MASS TO VOLUME RATIO, ECV, AND CIRCUM-
FERENTIAL STRAIN. Left ventricular mass to volume
ratio correlated signiﬁcantly with ECV (R ¼ 0.337,
p ¼ 0.006) and native T1 (R ¼ 0.341, p ¼ 0.006).
Circumferential strain and strain rate correlated
signiﬁcantly with LV mass to volume ratio (R ¼ 0.733,
p < 0.0001 and R ¼ 0.642, p < 0.0001, respectively).
DISCUSSION
In this study, T1 mapping by CMR showed greater
diffuse ﬁbrosis as measured by ECV in subjects with
HTN LVH compared with HTN non-LVH and control
FIGURE 3 Correlation of ECV and Native T1 With LVMI
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(A) ECV versus LVMI. Spearman correlation shows a positive association (Spearman rho ¼ 0.26, p ¼ 0.03) between ECV and LVMI. (B) Native
T1 and LVMI. Spearman correlation shows a positive association (Spearman rho ¼ 0.36, p ¼ 0.03) between native T1 levels and LVMI.
Abbreviations as in Figure 2.
Kuruvilla et al. J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 8 , N O . 2 , 2 0 1 5
ECV and Hypertensive LVH F E B R U A R Y 2 0 1 5 : 1 7 2 – 8 0
176subjects. Higher ECV values were associated with
reduced peak systolic circumferential strain and early
diastolic circumferential strain rate across all sub-
jects. Furthermore, native T1 levels were found to be
longer in HTN LVH subjects compared with normo-
tensive controls. Similarly, increased native T1 was
associated with reductions in peak circumferential
systolic strain and early diastolic strain rate. LeftFIGURE 4 Circumferential Strain and Strain Rates in the 3 Groups
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(A) Circumferential strain curves. (B) Circumferential strain rates in the 3
for the 3 groups are shown. Ecc ¼ circumferential strain; other abbreviaventricular mass to volume ratio also correlated with
strain and strain rate with increased mass to volume
ratio associated with increased ECV, increased native
T1, and reduced circumferential strain and strain rate.
ECV and native T1 have different sensitivity to the
underlying changes in the intracellular and extracel-
lular spaces within the myocardium. Native T1 is a
function of the relaxation of water in both thedE
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study groups. Average circumferential and circumferential strain rates
tions as in Figure 2.
TABLE 3 Strain and Strain Rate Among the 3 Groups
Normotensive
Controls
(n ¼ 22)
Hypertensive
Non-LVH
(n ¼ 23)
Hypertensive
LVH
(n ¼ 20)
Peak base circumferential strain 0.17  0.03 0.15  0.03 0.12  0.03*
Peak mid-circumferential strain 0.17  0.03 0.17  0.03 0.12  0.03*
Peak average circumferential strain 0.17  0.02 0.16  0.03 0.12  0.02*
Base e0SR (s
1) 0.81  0.17 0.68  0.17 0.48  0.27*
Mid e0SR (s
1) 0.83  0.19 0.72  0.23 0.43  0.22*
Average e0SR (s
1) 0.82  0.16 0.71  0.18 0.49  0.26*
Values are mean  SD. *p < 0.05 vs. non-LVH groups and controls.
e0SR ¼ early diastolic circumferential strain rate; LVH ¼ left ventricular hypertrophy.
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177extracellular and intracellular compartments and may
reﬂect both changes in cellular hypertrophy or extra-
cellular ﬁbrosis. As there is fast water exchange be-
tween these compartments, without giving contrast
the contribution of the intracellular and extracellular
compartments cannot be separated. Because gado-
linium contrast agents accumulate only in the extra-
cellular space, the post-contrast T1 shortening is
primarily due to a shortening of T1 relaxation time in
the extracellular space (although the measured T1 is
still affected by water exchange with the intracellular
compartment) (20). The ECV is calculated from a
combination of native and post-contrast measure-
ments and reﬂects the volume fraction of extracellular
space on a pixel-wise basis. Thus, native T1 and ECV
are sensitive to different compartments within the
myocardium and may each reﬂect different aspects
of the pathological changes of hypertensive heart
disease.
MYOCARDIAL FIBROSIS IN HYPERTENSION. Myocardial
ﬁbrosis is a common end point of many cellular and
noncellular pathological processes in hypertensive
heart disease. The pathogenesis of hypertensive heart
disease involves remodeling of the myocardium with
ﬁbrosis of the muscle and perivascular space, medial
hypertrophy of intramyocardial coronary vasculature,
and cardiomyocyte hypertrophy (21). The mecha-
nisms responsible for the development, progression,
and pattern of LVH are incompletely deﬁned but
include the severity and duration of hypertension,FIGURE 5 Correlation Between ECV and Circumferential Strain and
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ﬁbrosis predisposes patients to diastolic and systolic
dysfunction, myocardial ischemia, and atrial and
ventricular arrhythmias (23). A strong correlation has
been noted between increased myocardial collagen
content and left ventricular diastolic dysfunction by
echocardiography (24). This study also showed that
treatment with losartan reduced the collagen con-
tent and left ventricular stiffness. This suggests that
diffuse ﬁbrosis seen in hypertensive patients is
reversible in response to certain antihypertensive
therapies. Reduction in diffuse ﬁbrosis can result in
improvement of diastolic function, systolic function,
and perhaps outcomes. Thus, measurement of diffuse
ﬁbrosis levels could serve as a therapeutic target toStrain Rate
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FIGURE 6 Correlation Between Native T1 and Circumferential Strain and Strain Rate
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(A) Peak circumferential strain versus native T1. Pearson’s correlation shows a linear association between native T1 levels and peak circum-
ferential strain (Pearson’s correlation coefﬁcient of 0.44, p < 0.0001) and (B) average early diastolic circumferential strain rate versus native
T1. Pearson’s correlation shows a linear association between native T1 levels and average early diastolic circumferential strain rate (Pearson’s
correlation coefﬁcient of 0.40, p < 0.01). Abbreviations as in Figure 5.
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178measure the efﬁcacy of antihypertensive and other
therapies.
Initial animal studies in mice with hypertensive
heart disease have shown that measurement of ECV
as quantiﬁed by CMR T1 measurements can detect
extracellular matrix expansion due to underlying
interstitial ﬁbrosis (20). Our study likewise uses the
measurement of ECV of gadolinium as a surrogate
marker for underlying diffuse ﬁbrosis among the
study groups.
This is the ﬁrst study to measure the level of
diffuse ﬁbrosis using ECV in HTN LVH subjects
compared with HTN non-LVH subtypes using a
noninvasive imaging method. HTN LVH subjects in
this study had greater diffuse ﬁbrosis as measured by
ECV. The presence of diffuse ﬁbrosis may be an un-
derlying mechanism contributing to the increased
cardiovascular risk in HTN LVH subjects, and thera-
pies that modify diffuse ﬁbrosis may affect the risk.
The link between diffuse ﬁbrosis and increased car-
diovascular risk was examined in a recent study (25)
of heart failure patients with preserved EF and found
that shortened post-contrast T1 times, a marker of
diffuse ﬁbrosis, was associated with increased cardiac
events.
Although there is greater diffuse ﬁbrosis in HTN
LVH subjects, the association between ECV and LVMI
is nonlinear suggesting that there may be differential
stimulation of ﬁbrosis and myocyte hypertrophy in
these patients. The HTN non-LVH subjects had better
controlled blood pressures, and their LV mass was
not signiﬁcantly higher than that of control subjects.Fibrosis in these subjects was similar to that of
controls, and the lack of ﬁbrosis may be related to the
lower risk of cardiovascular events for this group.
NATIVE T1. Native T1 of HTN LVH subjects in this
study were signiﬁcantly higher than that of HTN non-
LVH or control subjects. Native T1 as discussed in
the preceding text is affected by both intracellular
myocardial tissue and the extracellular space. The
extracellular ﬁbrosis and myocardial cell hypertrophy
seen in HTN LVH patients contribute to elevated
native T1 levels. The measurement of native T1 as a
potential predictor of increased cardiovascular events
in LVH may have added value in that it does not
require contrast administration, which may otherwise
be contraindicated in those with stage 4 or 5 chronic
kidney disease.
DIFFUSE FIBROSIS AND SYSTOLIC STRAIN. Earlier
studies have shown reduced peak longitudinal and
radial systolic strain in hypertensive patients using
echocardiography and correlated the reduction in
strain with increased collagen synthesis and re-
duced collagen degradation (26). Studies using CMR
myocardial tagging have shown reduction in both
circumferential and longitudinal strain in HTN pa-
tients with LVH (27). In this study, HTN LVH subjects
were found to have signiﬁcantly reduced peak sys-
tolic circumferential strain and e0SR. We have also
shown a positive correlation among the peak systolic
circumferential strain, average e0SR, and increasing
levels of diffuse ﬁbrosis as measured by ECV and
native T1 levels, consistent with the expected
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179relationship between myocardial function and
ﬁbrosis. Reduced systolic strain has been previously
described in heart failure patients with preserved EF,
many of whom have HTN LVH and similar charac-
teristics (28). A possible mechanism linking ECV to
reduced systolic strain in such patients may be
increased extracellular matrix deposition leading to
increased LV stiffness, resulting in reduced end-
diastolic muscle ﬁber length and, by Frank-Starling’s
law, reduced cardiac muscle contraction and LV sys-
tolic strain. Indeed, prior studies have also shown
that diffuse ﬁbrosis has been linked with worsening
systolic/diastolic function and adverse LV remodeling
(23). However, further studies are needed to verify
this hypothesis.
STUDY LIMITATIONS. The study is limited by a rela-
tively small sample size; however, this is the largest
study to date evaluating ECV in hypertensive heart
disease and LVH. Given the small sample size of this
study, the effect of variables such as age, gender,
diabetes, hypertension duration, or antihypertensive
medications such as renin-angiotensin inhibitors on
ECV and native T1 could not be evaluated. Although
the severity of LVH by CMR was relatively mild in this
study, it was associated with increased levels of ECV
and higher native T1, suggesting signiﬁcantly greater
diffuse ﬁbrosis in the HTN LVH group compared with
the other groups. There are differing methods of T1
mapping, and although consensus guidelines have
recently been published regarding use of T1 mapping,
further research is needed before establishing a
standardized method of T1 mapping for clinical use
(29). The method that we used in this study was
previously compared with that of the standard MOLLI
technique and produced similar results (15). Also, the
applicability of results to an individual subject is less
certain given the higher variability of T1 relaxation
times and thus ECV when only measured in a single
subject. The use of multiple points for the calculation
of partition coefﬁcient and ECV in our study is ad-
vantageous because it allows us to check the
assumption of linearity at different time points to
verify the equilibrium assumption and enables anassessment of the uncertainty in determining l. The
use of only 2 time points (1 pre- and 1 post-contrast)
does not permit the measure of uncertainty of the ﬁt
and may be more sensitive to measurement outliers.
Two of our control subjects as mentioned in the pre-
ceding text had elevated ECV levels, and it is unclear
whether these results are due to normal variation or
due to undetermined pathologies.
FUTURE DIRECTIONS. There are limited data on the
prognostic value of diffuse ﬁbrosis as measured by
ECV in hypertensive subjects. Additionally, the
prognostic value of native T1 levels has yet to be
studied in this study population. Although diffuse
ﬁbrosis in HTN LVH subjects may be an underlying
mechanism that explains the increased cardiovascu-
lar morbidity and mortality seen in these subjects,
further studies are needed to conclusively link the
presence of diffuse ﬁbrosis with hard outcomes
in these patients. Currently, only 1 study has evalu-
ated the prognostic capability of T1 mapping in pre-
dicting cardiovascular events in a similar study
population (25).
CONCLUSIONS
The present study shows that HTN LVH patients have
greater diffuse ﬁbrosis and reduced circumferential
strain and circumferential strain rate compared with
HTN non-LVH and control subjects. Although diffuse
ﬁbrosis is linearly related to worsening circumferen-
tial strain, variations in ECV among patients with LVH
may provide insight into the differential expression
of ﬁbrosis and myocyte hypertrophy among patients
with hypertensive heart disease. Measurement of
ECV and native T1 levels may serve as a useful novel
target to monitor the efﬁcacy of therapies for HTN
patients.
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